| Indicators | Browse All

Cibus, Inc. (CBUS)

Healthcare | Biotechnology | San Diego, United States | NasdaqCM
2.13 USD +0.11 (5.446%) ⇧ (July 13, 2026, 4 p.m. EDT)

Short-term:★★⯪☆☆Long-term:★☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 6:03 a.m. EDT

The investment case for Cibus is currently broken by a catastrophic multi-year decline. Despite a recent uptick in price and a 'Buy' recommendation from analysts, the underlying business has suffered a 99.7% loss of value over the past eight years, with the most recent two years seeing double-digit percentage drops. The company is burning cash aggressively, reporting negative free cash flow and operating margins, while carrying a debt load nearly 78 times its equity. The balance sheet is fragile, and the lack of any dividend history confirms the capital is being consumed by operations. While the recent price action shows some life, the fundamental reality is a distressed biotech firm fighting for survival. The options market agrees with this pessimism, with traders buying insurance (puts) rather than betting on rallies. Until the company demonstrates a clear path to profitability or a massive catalyst to reverse the decade-long trend, this remains a high-risk speculative vehicle unsuitable for serious capital allocation.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
MSTL ✓0.060222
AutoETS0.069120
AutoTheta0.440876
AutoARIMA0.442504

Forecast horizon: 45 days | Selected: MSTL

Forecast Reliability
Score 34%
H-stat 1.20
Ljung-Box p 0.000
Jarque-Bera p 0.338
Excess Kurtosis 0.66
Attribute Value
Sector Healthcare
Debt to Equity Ratio 778.329
Revenue per Share 0.08
Market Cap 172,475,216
Forward P/E -3.38
Beta 1.65
Previous Name Calyxt, Inc.
Website https://www.cibus.com

As of July 11, 2026, 6:03 a.m. EDT: Speculators are overwhelmingly positioning for downside protection rather than upside speculation. Put open interest is concentrated entirely in-the-money strikes, with significant volume at the $2.50 strike, while call activity is negligible and limited to out-of-the-money strikes. This asymmetry suggests a market consensus expecting further weakness or a lack of confidence in immediate recovery.


Info Dump

Attribute Value
52 Week Change 0.3566879
Address1 6,455 Nancy Ridge Drive
All Time High 1,594.5
All Time Low 1.09
Ask 2.58
Ask Size 2
Average Analyst Rating 1.7 - Buy
Average Daily Volume10 Day 581,560
Average Daily Volume3 Month 376,460
Average Volume 376,460
Average Volume10Days 581,560
Beta 1.653
Bid 1.59
Bid Size 2
Book Value 0.465
City San Diego
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 2.13
Current Ratio 2.372
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 2.25
Day Low 1.9808
Debt To Equity 778.329
Earnings Call Timestamp End 1,778,790,600
Earnings Call Timestamp Start 1,778,790,600
Earnings Timestamp 1,778,788,800
Earnings Timestamp End 1,786,651,200
Earnings Timestamp Start 1,786,651,200
Ebitda -53,477,000
Ebitda Margins 0.0
Enterprise To Ebitda -7.637
Enterprise To Revenue 95.29
Enterprise Value 408,412,384
Eps Current Year -0.725
Eps Forward -0.63
Eps Trailing Twelve Months -1.77
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 1.4283
Fifty Day Average Change 0.7017001
Fifty Day Average Change Percent 0.4912834
Fifty Two Week Change Percent 35.66879
Fifty Two Week High 4.191
Fifty Two Week High Change -2.0609999
Fifty Two Week High Change Percent -0.49176803
Fifty Two Week Low 1.09
Fifty Two Week Low Change 1.0400001
Fifty Two Week Low Change Percent 0.9541285
Fifty Two Week Range 1.09 - 4.191
Financial Currency USD
First Trade Date Milliseconds 1,500,557,400,000
Float Shares 57,183,844
Forward Eps -0.63
Forward P E -3.3809526
Free Cashflow -52,742,500
Full Exchange Name NasdaqCM
Full Time Employees 118
Gmt Off Set Milliseconds -14,400,000
Gross Margins 1.0
Gross Profits 4,286,000
Has Pre Post Market Data 1
Held Percent Insiders 0.26133
Held Percent Institutions 0.33641997
Implied Shares Outstanding 80,974,270
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,685,577,600
Last Split Factor 1:5
Long Business Summary Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Long Name Cibus, Inc.
Market us_market
Market Cap 172,475,216
Market State PRE
Max Age 86,400
Message Board Id finmb_128307114
Most Recent Quarter 1,774,915,200
Name Change Date 2,026-07-09
Net Income To Common -101,421,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 162,204,722
Number Of Analyst Opinions 3
Open 1.985
Operating Cashflow -50,250,000
Operating Margins -7.20999
Payout Ratio 0.0
Phone 858 450 0008
Pre Market Change 0.0
Pre Market Change Percent 0.0
Pre Market Price 2.13
Pre Market Time 1,784,030,247
Prev Name Calyxt, Inc.
Previous Close 2.02
Price Eps Current Year -2.937931
Price Hint 4
Price To Book 4.5806456
Price To Sales Trailing12 Months 40.241535
Profit Margins 0.0
Quick Ratio 2.304
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key buy
Recommendation Mean 1.66667
Region US
Regular Market Change 0.11
Regular Market Change Percent 5.44555
Regular Market Day High 2.25
Regular Market Day Low 1.9808
Regular Market Day Range 1.9808 - 2.25
Regular Market Open 1.985
Regular Market Previous Close 2.02
Regular Market Price 2.13
Regular Market Time 1,783,972,800
Regular Market Volume 1,069,519
Return On Assets -0.1118
Return On Equity -1.9011999
Revenue Growth 0.626
Revenue Per Share 0.08
Sand P52 Week Change 0.20365608
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 76,331,634
Shares Percent Shares Out 0.060599998
Shares Short 4,629,455
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 4,795,697
Short Name Cibus, Inc.
Short Percent Of Float 0.081499994
Short Ratio 16.48
Source Interval 15
State CA
Symbol CBUS
Target High Price 25.0
Target Low Price 3.0
Target Mean Price 14.66667
Target Median Price 16.0
Total Cash 30,325,000
Total Cash Per Share 0.397
Total Debt 276,151,008
Total Revenue 4,286,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -1.77
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 1.8063
Two Hundred Day Average Change 0.32370007
Two Hundred Day Average Change Percent 0.17920615
Type Disp Equity
Volume 1,069,519
Website https://www.cibus.com
Zip 92,121